{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:31:20Z","timestamp":1789165880184,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009927","name":"Fidia Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijrobp.2025.09.037","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:41:35Z","timestamp":1759149695000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Toxicities and Quality of Life following Observation or Radiation Therapy for Dupuytren\u2019s Disease: Three-Year Secondary Analysis Data From the Prevention Group of the International Dupuytren's Evaluation of Preventative or Adjuvant Radiation Therapy (DEPART) Randomized Trial"],"prefix":"10.1016","volume":"124","author":[{"given":"Jarad M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.N.","family":"Werker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel J.H.M.","family":"Steenbakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreelakshmi","family":"Anoora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Sandoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sappiatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schlect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hunter-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.09.037_bib0001","unstructured":"The Royal College of Radiologists. Recommendations for using radiotherapy for benign disease in the UK; 2023.https:\/\/www.rcr.ac.uk\/our-services\/all-our-publications\/clinical-oncology-publications\/recommendations-for-using-radiotherapy-for-benign-disease-in-the-uk\/. Accessed October 19, 2025"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.adro.2018.02.008","article-title":"Updated strategies in the treatment of benign diseases-A patterns of care study of the German cooperative group on benign diseases","volume":"3","author":"Kriz","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0003","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-015-0818-2","article-title":"DEGRO guidelines for the radiotherapy of non-malignant disorders: Part III: Hyperproliferative disorders","volume":"191","author":"Seegenschmiedt","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.prro.2024.11.010","article-title":"Radiation therapy for Dupuytren contracture","volume":"15","author":"Yunes","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00066-010-2063-z","article-title":"Radiotherapy in early-stage Dupuytren\u2019s contracture. Long-term results after 13 years","volume":"186","author":"Betz","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0006","series-title":"Dupuytren\u2019s Disease and Related Hyperproliferative Disorders","first-page":"349","article-title":"Long-term outcome of radiotherapy for early stage Dupuytren\u2019s disease: A phase III clinical study","author":"Seegenschmiedt","year":"2012"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0007","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","article-title":"Prevalence of Dupuytren disease in the Netherlands","volume":"132","author":"Lanting","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1753193417695996","article-title":"Radiotherapy in Dupuytren\u2019s disease: A systematic review of the evidence","volume":"42","author":"Kadhum","year":"2017","journal-title":"J Hand Surg Eur"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0009","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMicm1814119","article-title":"Palmar squamous-cell carcinoma","volume":"381","author":"Campanelli","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib30","unstructured":"ANZCTR, Assessment of radiotherapy in the management of Dupuytren\u2019s disease. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=375241. Accessed October 19, 2025."},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/acr.20564","article-title":"Unit\u00e9 Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren\u2019s disease-specific disability","volume":"63","author":"Beaudreuil","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0011","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PRS.0000000000009115","article-title":"Disease course of primary Dupuytren disease: 5-year results of a prospective cohort study","volume":"149","author":"Broekstra","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0012","doi-asserted-by":"crossref","first-page":"pzae033","DOI":"10.1093\/ptj\/pzae033","article-title":"Minimal clinically important difference of the Disabilities of the Arm, Shoulder and Hand (DASH) and the shortened version of the DASH (QuickDASH) in people with musculoskeletal disorders: A systematic review and meta-analysis","volume":"104","author":"Galardini","year":"2024","journal-title":"Phys Ther"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0013","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.136.8.1007","article-title":"Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group","volume":"136","author":"Lichter","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0014","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180677","article-title":"Cancer incidence after childhood irradiation for tinea capitis in a Portuguese cohort","volume":"93","author":"Antunes","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004032-200310000-00003","article-title":"Tumors and other diseases following childhood x-ray treatment for ringworm of the scalp (Tinea capitis)","volume":"85","author":"Shore","year":"2003","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0016","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150405","article-title":"Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation","volume":"88","author":"McKeown","year":"2015","journal-title":"Br J Rad"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.06.1161","article-title":"Risk of radiation-induced malignancies following low-dose orthovoltage therapy for painful joint and tendon disorders: A retrospective analysis","volume":"123","author":"Blach","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0017","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijrobp.2015.02.009","article-title":"Prospective randomized comparison of the effectiveness of radiation therapy and local steroid injection for the treatment of plantar fasciitis","volume":"92","author":"Canyilmaz","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109718","article-title":"Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial","volume":"185","author":"de Haan","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0019","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/09553002.2025.2473975","article-title":"Effects of low dose rate radiotherapy on pain relief, performance score, and quality of life in patients with knee osteoarthritis; a double-blind sham-controlled randomized clinical trial","volume":"101","author":"Fazilat-Panah","year":"2025","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0020","unstructured":"Jutkowitz E, Rieke K, Caputo EL, et al. Radiation therapy for benign conditions: A systematic review. Evidence Synthesis Program , Health Systems Research, Office of Research and Development, Department of Veterans Affairs. 2024. https:\/\/www.hsrd.research.va.gov\/publications\/esp\/Radiation-Benign-Conditions.cfm. Accessed October 19, 2025."},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0021","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2665-9913(19)30096-7","article-title":"Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: Follow-up results of two parallel randomised, sham-controlled trials","volume":"2","author":"van den Ende","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00066-023-02152-z","article-title":"ArthroRad trial: Randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis-final results after 12-month follow-up","volume":"200","author":"Niewald","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0024","doi-asserted-by":"crossref","first-page":"E407","DOI":"10.1016\/S2665-9913(22)00093-5","article-title":"Anti-tumour necrosis factor therapy for early-stage Dupuytren\u2019s disease (RIDD): A phase 2b, randomised, double-blind, placebo-controlled trial","volume":"4","author":"Nanchahal","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0026","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0034-1394420","article-title":"Dupuytren contracture recurrence project: Reaching consensus on a definition of recurrence","volume":"46","author":"Felici","year":"2014","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0027","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(00)00745-8","article-title":"Radiotherapy optimization in early-stage Dupuytren\u2019s contracture: First results of a randomized clinical study","volume":"49","author":"Seegenschmiedt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0028","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year results of a randomized clinical trial on treatment in Dupuytren\u2019s disease: Percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"van Rijssen","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ijrobp.2025.09.037_bib0029","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/17531934251321393","article-title":"Adverse events after adjuvant radiation therapy for Dupuytren\u2019s disease in the DEPART randomized trial","volume":"50","author":"Burgess","year":"2025","journal-title":"J Hand Surg Eur"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162506300X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162506300X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:48:34Z","timestamp":1773272914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162506300X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S036030162506300X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.037","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicities and Quality of Life following Observation or Radiation Therapy for Dupuytren\u2019s Disease: Three-Year Secondary Analysis Data From the Prevention Group of the International Dupuytren's Evaluation of Preventative or Adjuvant Radiation Therapy (DEPART) Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}